Principal Financial Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-68,620
| Closed | -$1.95M | – | 2519 |
|
2023
Q1 | $1.95M | Sell |
68,620
-2,285
| -3% | -$64.8K | ﹤0.01% | 1768 |
|
2022
Q4 | $2.07M | Sell |
70,905
-384
| -0.5% | -$11.2K | ﹤0.01% | 1756 |
|
2022
Q3 | $1.88M | Sell |
71,289
-10,970
| -13% | -$290K | ﹤0.01% | 1721 |
|
2022
Q2 | $3.66M | Sell |
82,259
-936
| -1% | -$41.6K | ﹤0.01% | 1660 |
|
2022
Q1 | $4.12M | Sell |
83,195
-4,702
| -5% | -$233K | ﹤0.01% | 1724 |
|
2021
Q4 | $4.48M | Sell |
87,897
-10,719
| -11% | -$546K | ﹤0.01% | 1707 |
|
2021
Q3 | $5.5M | Sell |
98,616
-2,370
| -2% | -$132K | ﹤0.01% | 1654 |
|
2021
Q2 | $4.32M | Sell |
100,986
-9,653
| -9% | -$413K | ﹤0.01% | 1752 |
|
2021
Q1 | $4.62M | Buy |
110,639
+2,286
| +2% | +$95.4K | ﹤0.01% | 1687 |
|
2020
Q4 | $5.05M | Buy |
108,353
+1,022
| +1% | +$47.6K | ﹤0.01% | 1555 |
|
2020
Q3 | $4.56M | Buy |
107,331
+20,781
| +24% | +$883K | ﹤0.01% | 1487 |
|
2020
Q2 | $4.15M | Sell |
86,550
-249
| -0.3% | -$11.9K | ﹤0.01% | 1498 |
|
2020
Q1 | $3.99M | Sell |
86,799
-3,131
| -3% | -$144K | ﹤0.01% | 1376 |
|
2019
Q4 | $5.4M | Buy |
89,930
+10,160
| +13% | +$610K | ﹤0.01% | 1512 |
|
2019
Q3 | $4.51M | Sell |
79,770
-2,869
| -3% | -$162K | ﹤0.01% | 1551 |
|
2019
Q2 | $4.6M | Sell |
82,639
-162
| -0.2% | -$9.02K | ﹤0.01% | 1556 |
|
2019
Q1 | $4.18M | Sell |
82,801
-6,488
| -7% | -$328K | ﹤0.01% | 1604 |
|
2018
Q4 | $3.6M | Sell |
89,289
-669
| -0.7% | -$27K | ﹤0.01% | 1600 |
|
2018
Q3 | $6.24M | Buy |
89,958
+25,120
| +39% | +$1.74M | 0.01% | 1533 |
|
2018
Q2 | $4.91M | Sell |
64,838
-9,047
| -12% | -$685K | ﹤0.01% | 1599 |
|
2018
Q1 | $3.89M | Buy |
73,885
+2,436
| +3% | +$128K | ﹤0.01% | 1626 |
|
2017
Q4 | $3.82M | Sell |
71,449
-1,504
| -2% | -$80.3K | ﹤0.01% | 1638 |
|
2017
Q3 | $4.35M | Buy |
72,953
+4,963
| +7% | +$296K | ﹤0.01% | 1595 |
|
2017
Q2 | $5.36M | Buy |
67,990
+5,954
| +10% | +$470K | 0.01% | 1526 |
|
2017
Q1 | $5.15M | Buy |
62,036
+3,879
| +7% | +$322K | 0.01% | 1522 |
|
2016
Q4 | $4.61M | Buy |
58,157
+19
| +0% | +$1.51K | 0.01% | 1541 |
|
2016
Q3 | $4.07M | Buy |
+58,138
| New | +$4.07M | 0.01% | 1525 |
|